The research team, led by Simbarashe Chinyowa of the University of Zimbabwe together with colleagues at the University of Cape Town and the University of California San Francisco, interviewed thirteen recently diagnosed colorectal cancer patients and thirteen of their caregivers. The participants were recruited consecutively from five major hospital sites across the country, including Parirenyatwa Group of Hospitals and Sally Mugabe Central Hospital in Harare, Chitungwiza Central Hospital, and Mpilo Hospital and the United Bulawayo Hospitals in Bulawayo. All of the patients were symptomatic and had been admitted either electively or as emergencies for colorectal surgery. Crucially, the study included four patient-caregiver dyads, allowing the researchers to compare how the same diagnostic journey was experienced by both the person with cancer and the family member supporting them.

The interviews were audio-recorded, transcribed and translated into English, then analysed using inductive coding guided by the Model of Pathways to Treatment, a well-established framework that divides the diagnostic journey into distinct intervals: the time before a patient recognises something is wrong, the time before they seek help, and the time between first presenting to the health system and receiving a definitive diagnosis. This structure allowed the team to pinpoint exactly where in the journey delays occur and what factors either accelerate or obstruct progress at each stage. Ethical approval was granted by the Joint Research Ethics Committee for the University of Zimbabwe Faculty of Health Sciences and Parirenyatwa Group of Hospitals and by the Medical Research Council of Zimbabwe, and all participants gave written and verbal consent.

The first interval, known as the appraisal interval, turned out to be shaped by powerful psychological and cultural forces. Many patients normalised their symptoms, interpreting rectal bleeding, changes in bowel habits or abdominal discomfort as ordinary complaints that did not warrant medical attention. A widespread belief in the body’s capacity to heal itself encouraged a wait-and-see approach, while some participants described a perceived futility of treatment, a fatalism that suggested even a diagnosis would change little. These beliefs kept people away from clinics during the critical early window when colorectal cancer is most treatable. The researchers found that this phase of the journey, before any contact with the health system, could consume enormous amounts of time, silently allowing tumours to progress.

What finally pushed patients to seek help was often the arrival of alarming symptoms that could no longer be ignored, or the persistence and worsening of symptoms over time. Social networks also played a decisive role: family members, friends and neighbours who noticed something wrong and urged the patient to visit a health facility frequently tipped the balance toward action. This finding underscores a recurring theme in the study, namely that in the Zimbabwean context the diagnostic journey is rarely a solo undertaking. It is a family project, shaped by collective decision-making, shared resources and, in many cases, the appointment of a designated caregiver who accompanied the patient through every stage of care.

Once patients decided to seek help, a second set of obstacles emerged. The most prominent were financial: many participants simply lacked the money to pay for consultations, transport, investigations or the medications needed along the diagnostic pathway. Logistical barriers compounded the problem, particularly when the nearest facility offering colorectal services was far from home. The study notes that these burdens were amplified by distance, meaning that patients in rural or remote areas faced a double disadvantage of higher travel costs and longer journeys. In a health system where patients frequently must fund much of their own care out of pocket, the ability to reach a hospital and pay for a colonoscopy can be the difference between early detection and a late-stage emergency admission.

Family support emerged as the single most important facilitator during this help-seeking interval. When relatives could contribute money, provide transport or accompany the patient to appointments, the journey moved forward. The designation of a caregiver who acted as a chaperone during all health-related visits proved especially valuable, ensuring that patients who were unwell, unfamiliar with the system or unable to advocate for themselves still made it to the right place at the right time. The researchers argue that this caregiving role is an underappreciated asset in cancer control, one that health systems could deliberately support rather than leave to chance.

The third phase, the diagnostic interval between first presentation and confirmed diagnosis, revealed systemic weaknesses inside the health facilities themselves. Services for colorectal cancer are heavily centralised in a handful of hospitals, forcing patients to travel long distances for specialist assessment and endoscopy. High costs persisted at this stage as well, and inefficient consultation scheduling meant that appointments were delayed or lost. Misdiagnoses added further delay, with some patients initially treated for other conditions before the cancer was recognised. Each of these barriers added weeks or months to a journey that had often already stretched over a year, pushing patients closer to the advanced presentations that dominate colorectal cancer care in the region.

Yet the study also documents what good care looks like when the system functions. Participants reported positive experiences when there was strong rapport between patient and doctor, when healthcare workers were knowledgeable about colorectal cancer, and when clear referral prompts and pathways were provided. Notably, social welfare department support proved vital to the successful diagnosis of several participants, helping to cover costs that would otherwise have halted the journey entirely. These facilitators, the authors suggest, are not expensive to replicate: training frontline clinicians to recognise red-flag symptoms, streamlining referral pathways and strengthening social welfare mechanisms could all shorten the diagnostic interval substantially.

The study’s conclusions point in two directions at once. From a public health education perspective, the findings argue for campaigns that counter symptom normalisation and the belief in body self-healing, teaching communities that rectal bleeding and persistent bowel changes demand medical attention. From a health system policy perspective, they call for decentralising diagnostic services, reducing costs, improving scheduling and building formal support for the caregivers who already carry so much of the load. With colorectal cancer incidence climbing steadily in Zimbabwe and across sub-Saharan Africa, and with most patients still diagnosed too late for curative treatment, the voices of these twenty-six patients and caregivers provide a rare and valuable roadmap, showing precisely where the journey to diagnosis breaks down and, just as importantly, what keeps it moving.

Subject of Research: Barriers and facilitators to timely colorectal cancer diagnosis in Zimbabwe

Article Title: Barriers and facilitators to colorectal cancer diagnosis in Zimbabwe: a qualitative study

Article References: Chinyowa, S., Chitukuta, M., Katsidzira, L., Chirenje, M. Z., Muguti, G., & Moodley, J. (2026). Barriers and facilitators to colorectal cancer diagnosis in Zimbabwe: a qualitative study. BMC Cancer. https://doi.org/10.1186/s12885-026-17064-1

Image Credits: AI Generated

DOI: 10.1186/s12885-026-17064-1

Keywords: colorectal cancer, Zimbabwe, cancer diagnosis, qualitative research, caregivers, health systems, sub-Saharan Africa, patient pathways, diagnostic delay, health communication, cancer screening, social welfare

The core of the model is a regional surgical indication tumour board hosted at the NCT Dresden. In modern oncology, treatment decisions are ideally made not by a single physician but by an interdisciplinary panel of surgeons, medical and radiation oncologists, radiologists, and pathologists who review each case together. In practice, however, patients treated in smaller rural hospitals frequently never reach such a board, because the expertise is concentrated in urban maximum-care centres. MISSION4Sax brings the board to the region: cases from participating rural hospitals and oncology practices are presented to the central panel, which then issues evidence-based, standardised treatment recommendations. The goal is that every patient in the network, regardless of postcode, receives a guideline-based therapy recommendation and, where appropriate, access to innovative surgery and clinical trials.

To translate those recommendations into coordinated care, the study develops and pilots standardised patient care pathways across three regional hospitals and two oncology practices in East Saxony. These pathways define, step by step, what should happen after a cancer diagnosis: which diagnostics are needed, when the tumour board should be consulted, how surgery or systemic therapy is scheduled, and how follow-up is organised. Pathways of this kind are intended to reduce waiting times, prevent duplication of examinations, and make deviations from guideline care visible and correctable. The pilot study is explicitly exploratory and prospective in design, following patients longitudinally to assess how the model performs under real-world conditions rather than testing the causal effectiveness of any single intervention.

Because a care model is only as good as the data infrastructure beneath it, MISSION4Sax places unusual emphasis on study management and digital coordination. The project builds its database on the infrastructure of the NCT Core Unit Registry Trial Platform, a professional research data system already used for other oncology registry studies. Targeted training programmes prepare staff at the participating sites for the new processes, from documentation standards to communication routines. Perhaps the most distinctive element is the deployment of so-called Flying Data Nurses: mobile study personnel who travel between the rural hospitals and practices to support coordination, data flow, and communication on site. This travelling workforce is meant to solve a chronic problem in multicentre research, where small institutions often lack dedicated study staff and data quality suffers as a result.

The researchers also widen the lens beyond clinical measurements. Patient-reported outcomes, collected systematically, complement the clinical data and capture how patients themselves experience the care pathway: their symptoms, quality of life, and satisfaction with coordination and information. In addition, routinely collected health insurance data will be used strictly as external reference material for a descriptive comparison with the MISSION4Sax cohort. The protocol is careful to specify that no individual-level data linkage will be performed with these insurance records, a design choice that reflects both privacy considerations and the pilot character of the study. A mixed-methods process evaluation will run alongside the entire project, combining quantitative indicators with qualitative interviews and observations to understand not just whether the model functions, but why, for whom, and under what conditions.

What the study will actually measure follows directly from its feasibility focus. The team plans to assess whether the care model can be implemented in routine care, whether patients and professionals find it acceptable, and how well the study infrastructure supports data quality. Secondary exploratory questions concern access to specialised care, waiting times from diagnosis to treatment, adherence to the defined pathways, coordination between sectors, and clinical as well as patient-reported outcomes. This framing matters scientifically: many promising care innovations fail not because the underlying medicine is wrong but because logistics, communication, and workload make them unsustainable. By testing feasibility, acceptability, implementation, and data quality first, MISSION4Sax follows the recognised logic of pilot studies that prepare the ground for later, larger trials of effectiveness.

The regional context gives the project its urgency. East Saxony combines mid-sized towns and villages with long travel distances to tertiary centres, and like many rural areas in Germany and across Europe it faces a shortage of specialists and growing pressure on hospital infrastructure. For surgical oncology in particular, where the choice of operation, the timing of neoadjuvant therapy, and the availability of high-volume expertise can decisively influence outcomes, the distance between a patient and a maximum-care centre is not a trivial inconvenience. Strengthening cancer care infrastructure, interdisciplinary cooperation, and digital systems, the authors argue, may support equitable access to high-value care in rural regions, so that the quality of treatment no longer depends on where a patient happens to live.

The study is registered in the German Clinical Trials Register under identifier DRKS00036134, with registration dated 30 June 2025. Ethical approval was granted by the Ethics Committee of TUD Dresden University of Technology, and the study will be conducted in line with the principles of the Declaration of Helsinki, with informed consent obtained from all participants. The project is funded by the German Federal Ministry of Research, Technology and Space under grants 01KD2402A and 01KD2402B, with the funding institution explicitly not interfering in any part of the study. The participating institutions named in the acknowledgements include Krankenhaus Bautzen, Asklepios-ASB Krankenhaus Radeberg, Klinikum Oberlausitzer Bergland in Zittau, and two oncology care providers in the region, forming the practical backbone of the network.

For the wider field of health services research, the protocol offers a template worth watching. It combines a central specialist resource, standardised pathways, professional data management, mobile study staff, and systematic patient-reported measures into a single regional architecture, and it documents the evaluation plan in enough detail that other regions could replicate or adapt it. If the pilot demonstrates that the tumour board, the pathways, and the trained staff improve care quality and collaboration across sectors, the model could inform how rural cancer networks are built well beyond Saxony. Conversely, if the process evaluation reveals friction points, whether in documentation burden, communication delays, or staff capacity, those findings will be equally valuable, identifying precisely where investment is needed before the model is scaled.

The first results will show whether a Flying Data Nurse with a laptop and a central tumour board can do what decades of structural reform have struggled to achieve: make excellent cancer surgery and trial access a matter of course, rather than geography, for patients in the countryside. As the authors conclude, the proposed tumour board, patient pathways, and trained staff may improve care quality and collaboration across sectors, and the pilot study now underway in East Saxony will provide the evidence on whether that promise holds in the demanding reality of routine clinical care.

Subject of Research: A multicentre pilot study protocol for cross-sectoral oncological care, data integration, and rural-urban networking in East Saxony

Article Title: Optimized surgical treatment and study management for oncology patients in East Saxony (MISSION4Sax): study protocol of a multicentre pilot study

Article References: Richter, C., Döring, A., Berg, F., Roost, M., Hasselberg, A., Martin, C., Schlieter, H., Piontek, D., Schoffer, O., Schmitt, J., Weitz, J., Krause-Jüttler, G., & Kirchberg, J. (2026). Optimized surgical treatment and study management for oncology patients in East Saxony (MISSION4Sax): study protocol of a multicentre pilot study. Journal of Cancer Research and Clinical Oncology, 152(9), Article 173. https://doi.org/10.1007/s00432-026-06599-2

Image Credits: AI Generated

DOI: 10.1007/s00432-026-06599-2

Keywords: surgical oncology, multidisciplinary tumour board, patient pathways, health services research, rural healthcare access, cancer care networks, pilot study, patient-reported outcomes, data quality, Germany, clinical trials, health equity